Radiologix Names Stephen D. Linehan President and Chief Executive Officer; Healthcare Executive Brings Strong Record of Successful Operations Experience

Radiologix Names Stephen D. Linehan President and Chief Executive Officer; Healthcare Executive Brings Strong Record of Successful Operations Experience

		RADIOLOGIX LOGO Based in Dallas, Texas, Radiologix is a leading radiology services company that develops, consolidates and manages radiology service networks. These networks consist primarily of free-standing radiology centers and locations at which the company provides radiology services that have been outsourced by hospitals. The company's objective is to develop and operate networks of radiology facilities to provide a full spectrum of radiology services and extensive geographic coverage in existing market areas and in selected new markets. (PRNewsFoto) [JL] DALLAS, TX USA

		RADIOLOGIX STEPHEN LINEHAN Stephen D. Linehan, president and chief executive officer of Radiologix,Inc. (Amex: RGX). (PRNewsFoto)[TC] DALLAS, TX USA

DALLAS, Feb. 6 /PRNewswire-FirstCall/ -- Radiologix, Inc. (Amex: RGX), a leading national provider of diagnostic imaging services, today announced that Stephen D. Linehan has been named President and Chief Executive Officer (CEO) effective immediately. Radiologix also announced the resignation of President and Chief Operating Officer, Mark S. Martin, to pursue other opportunities. Mr. Linehan, 52, a successful and experienced chief executive, has worked for more than two decades providing leadership to and managing the operations of various healthcare organizations. Most recently, Mr. Linehan served as President and Chief Executive Officer of Rotech Healthcare, Inc. (OTC: ROHI). Rotech Healthcare is a leading provider of home respiratory care and durable medical equipment and services to patients with breathing disorders. It provides equipment and services in 48 states through over 600 operating centers across the U.S. It had over $600 million in revenue in 2001. While with Rotech Healthcare, Mr. Linehan successfully achieved the highest organic growth in the industry both in medications and in new oxygen therapy by focusing management on operations and field marketing. "We are extremely pleased to have an executive of Steve's caliber joining the Radiologix team," said Marvin S. Cadwell, Chairman of the Board of Directors of Radiologix. "His breadth and depth of healthcare operating experience, particularly with multi-site providers, and his demonstrated ability to grow shareholder value, will be very beneficial for Radiologix." During his 30-year career, Mr. Linehan has held executive and board-level positions with public and private companies in the healthcare industry, including serving as President of Value Rx, Inc., a $1 billion pharmacy benefits management unit of Value Health, Inc. As part of the original management team, Mr. Linehan was instrumental in growing Value Health from a $25 million dollar early-stage venture investment into a $1.5 billion-in- revenue, NYSE-listed company. "This represents a tremendous opportunity because Radiologix is a solid company with a good model in a growing sector of healthcare," said Mr. Linehan. "Diagnostic imaging is medically necessary for determining course of care and follow-up. It will continue to grow as the populations ages, as technologies improve, as referring physicians become more comfortable with new technologies, as healthcare consumers understand options available and as payors continue to recognize the value of effectively managed diagnostic imaging." Mr. Linehan has served on several Boards of Directors, including: FHC Health Systems, OPTIONS Health Care, Value Rx, American PsychManagement, Hurst Associates, and Wellington Life Insurance Company. Mr. Linehan served two terms as Mayor of the City of Lake St. Louis, MO, from April 1983 to April 1987. In this part-time position, Mr. Linehan directed all city staff and the multi-million dollar city budget. He supervised the Police Department, Planning and Zoning Commission and the City Manager. Mr. Linehan earned a B.S. degree in Business Administration from the University of North Dakota and an M.B.A. from Lindenwood University in St. Charles, MO. Mr. Martin's Resignation Radiologix also announced the resignation of Mark S. Martin, President and Chief Operating Officer. Mr. Martin joined Radiologix in 1996 and has been an important part of the company's growth over the last six years. "We want to thank Mark for his many contributions to Radiologix and wish him much luck in his future endeavors," said Mr. Cadwell. About Radiologix Radiologix (http://www.radiologix.com ) is a leading national provider of diagnostic imaging services through (i) its ownership and operation of technologically advanced, multi-modality diagnostic imaging centers, and (ii) its provision of administrative, management and other information services to certain radiology business partners. Radiologix derives the majority of its revenues from the production and management of diagnostic imaging procedures utilizing technologies such as x-ray, magnetic resonance imaging ("MRI"), computed tomography ("CT"), mammography, ultrasound, nuclear medicine and positron emission tomography ("PET"), as well as general radiography and fluoroscopy. These images, and the radiology reports that are based on these images, permit ordering physicians to diagnose and manage diseases and injuries more accurately and effectively than would be possible without this clinical information. Radiologix owns or operates 117 imaging centers located in 17 states, with concentrated geographic coverage in markets located in California, Florida, Kansas, Maryland, New York, Texas and Virginia. Safe Harbor Statement This press release contains forward-looking statements that relate to future financial results or business expectations and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that exist in the Company's operations and business environment. Business plans may change as circumstances warrant and actual results may differ materially from any forward-looking statements, which reflect the management's opinion only as of the date hereof. Such risks and uncertainties include, but are not limited to, those associated with the Company's acquisition and expansion strategy; integration of the Company's affiliated physician practices and newly-acquired imaging centers; the Company's ability to achieve operating efficiencies and engage in successful new development efforts; regulatory changes; reimbursement trends; governmental policies; and general economic and business conditions. Such risks and uncertainties, as well as additional risk factors which could affect the forward-looking statements made in this press release, are included in the Company's filings with the Securities and Exchange Commission, including its Form 10-K dated March 28, 2002. Any forward-looking statement speaks only as of the date on which such statement is made. Radiologix undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement is made.